Skip to ContentSkip to Navigation
How to find us dr. P.M. Houtman

Publications

Patient-tailored dose reduction of TNF-alpha blocking agents in ankylosing spondylitis patients with stable low disease activity in daily clinical practice

Daily physical activity in ankylosing spondylitis: validity and reliability of the IPAQ and SQUASH and the relation with clinical assessments

Validity and Reliability of the Dutch Adaptation of the Psoriatic Arthritis Quality of Life (PsAQoL) Questionnaire

EARLY CHANGE IN BONE RESORPTION PREDICTS DISCONTINUATION OF TUMOR NECROSIS FACTOR-ALPHA BLOCKING THERAPY IN PATIENTS WITH ANKYLOSING SPONDYLITIS

Parameters related to a positive test result for FDG PET(/CT) for large vessel vasculitis: a multicenter retrospective study

SYNDESMOPHYTES ARE ASSOCIATED WITH HIGHER BONE TURNOVER IN ANKYLOSING SPONDYLITIS PATIENTS WITH ACTIVE DISEASE

The effect of three years of TNF alpha blocking therapy on markers of bone turnover and their predictive value for treatment discontinuation in patients with ankylosing spondylitis: a prospective longitudinal observational cohort study

Baseline predictors of response and discontinuation of tumor necrosis factor-alpha blocking therapy in ankylosing spondylitis: a prospective longitudinal observational cohort study

Serum MMP-3 Level as a Biomarker for Monitoring and Predicting Response to Etanercept Treatment in Ankylosing Spondylitis

The relation between bone mineral density, bone turnover markers, and vitamin D status in ankylosing spondylitis patients with active disease: a cross-sectional analysis

Read more